Mounjaro vs Lantus: side-by-side comparison
Mounjaro (Tirzepatide) and Lantus (Insulin Glargine) both belong to the Diabetes Treatment class. They share clinical context but use different active ingredients. The choice between them depends on mechanism nuances, side-effect profile and individual response.
| Property | Mounjaro | Lantus |
|---|---|---|
| Active ingredient | Tirzepatide | Insulin Glargine |
| Manufacturer | Eli Lilly | Sanofi |
| Class | Diabetes Treatment | Diabetes Treatment |
| Strengths | 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, 15mg | 100 IU/mL |
| Forms | pre-filled pen | pre-filled pen, vial |
What's the same
Mounjaro and Lantus both belong to the Diabetes Treatment class and are used for partially overlapping indications. The active ingredients — Tirzepatide vs Insulin Glargine — share the same therapeutic approach, so many safety and management points carry across both.
Key differences
Meaningful differences are in active ingredient (Tirzepatide vs Insulin Glargine), strengths (2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, 15mg vs 100 IU/mL), forms (pre-filled pen vs pre-filled pen, vial), and the mechanism, half-life and side-effect nuances that distinguish members of the class.
Mechanism and action
Mounjaro: Tirzepatide binds with high affinity to both the GIP and the GLP-1 receptors. Lantus: Insulin glargine binds the insulin receptor with similar affinity to human insulin, activating intracellular signalling that increases glucose uptake in muscle and adipose tissue, suppresses hepatic glucose production an…
When Mounjaro is preferred
The medication is indicated in adults with type 2 diabetes mellitus, alone or in combination with other antidiabetic agents, to improve glycaemic control.
When Lantus is preferred
The medication is indicated in adults and paediatric patients with type 1 diabetes mellitus, and in adults with type 2 diabetes mellitus when basal insulin is required.
Frequently asked questions
Is Mounjaro or Lantus better? ▾
There is no single answer. Mounjaro and Lantus both belong to the Diabetes Treatment class but differ in mechanism nuances, half-life and side-effect profile. Preference depends on the patient, the prescriber and prior response to other therapies.
Can I switch from Mounjaro to Lantus? ▾
Switching within the Diabetes Treatment class is done under supervision, typically using equivalent doses and a follow-up period to confirm response and tolerance. It is not a self-directed decision.
Do Mounjaro and Lantus have the same side effects? ▾
They share many of the Diabetes Treatment class side effects, with differences from mechanism and dose. Each medication's prescribing information lists specifics.
More Mounjaro comparisons
The information on this website is provided for reference and educational purposes only. It does not replace consultation with a qualified healthcare professional.